In the world of health care innovation, speed matters. But when it comes to developing and deploying cutting-edge treatments and therapeutics safely, a cautious and methodical approach is vital as well. Safety matters as much as speed, but faster doesn’t always mean riskier. In her latest blog, AMCP CEO Susan Cantrell discusses the history of the Pre-approval Information Exchange (PIE) Act and how it will help patients.
In this guest blog post, Jennifer Graff, PharmD , discusses incorporating value in coverage decisions and how this applies to AMCP's efforts in addressing value and access.
In 2016, AMCP made pre-approval information exchange (PIE) a legislative priority recognizing its vital importance to patients. On June 8, 2022, the U.S. House of Representatives passed the PIE Act of 2022. Learn more about PIE as a legislative priority for AMCP.
From best practices in managing obesity to the latest and greatest in gene and cell therapies, guest blogger Steve Kheloussi highlights three reasons he will be attending AMCP eLearning Day.
In her latest blog, AMCP CEO Susan Cantrell recaps our inaugural workshop on the IRA, reinforcing that there is still a great deal of uncertainty as key milestones approach. Learn how AMCP is addressing concerns this landmark legislation is causing across managed care pharmacy and the larger healthcare industry.
In June, AMCP hosted the Deep Dive into Prescription Digital Therapeutics Summit, convening expert panelists and attendees from across the industry. Read 10 key takeaway points from the Summit.